FDA label
What is Qulipta used for?
Qulipta contains atogepant. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “QULIPTA is indicated for the preventive treatment of migraine in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Qulipta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Qulipta, tablet
Indications and Usage, quoted from the label by AbbVie Inc. (NDA215206). Cross-references to other label sections are left out.
QULIPTA is indicated for the preventive treatment of migraine in adults.
Source: DailyMed label, set id 8c8ab8f4-32bd-497a-befa-70c8a51d8d52, version 19, effective September 30, 2025. NDC 0074-7094, one of 3 listings for this product.
Questions
What is Qulipta used for?
The FDA label says: “QULIPTA is indicated for the preventive treatment of migraine in adults.”
What drug class is Qulipta?
FDA lists atogepant in the Calcitonin Gene-related Peptide Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.